Key Details and Deadlines
All poster presenters will receive a link in by the end of September to upload their posters. The link will be active the week of October 1-15. All posters MUST be uploaded by October 15, or they will not be included in TLMdX.
All poster presenters of The Liver Meeting Digital Experience™ are required to:
- Register for and attend the Annual Meeting.
- Visit the Speaker Center to review your session details.
- Download the official AASLD TLMdX ePoster Template to develop your presentation.
- Review AASLD's Copyright License Agreement and Faculty Presentation Agreement Form presented in your Speaker Center.
- Confirm that the content you are preparing for presentation meets AASLD's Disclosure Policy and the ACCME Standards for Integrity and Independence in Accredited Continuing Education.
- Indicate all relevant financial disclosures on the bottom right-hand corner of your poster.
- Upload your presentation no later than October 15, 2021, to ensure all presentations are successfully transitioned into the digital format for the meeting.
Plan accordingly! There are no exceptions for late submissions received or requests for revisions after the October 15, 2021 deadline.
The Speaker Center is your one-stop-shop to view your confirmed faculty engagements and session information, and to plan your meeting schedule.
Preparing Content and Deliverables
A poster session is comprised of simultaneous informal presentations by several investigators. To communicate with all interested attendees, the best approach is to minimize the specific details presented on the poster and to maximize the transfer of information by creating an audio file to accompany your poster. Remember that your scientific message must be legible and clearly stated to the viewer.
PREPARE YOUR DIGITAL POSTER
- Posters should not exceed 10 MB in size. The preferred file type is PDF.
- Poster presenters will also have the opportunity to upload an OPTIONAL audio file to accompany their posters to describe their work. Audio files must be provided in MP3 format. It is recommended that audio files be approximately 5 minutes in length.
- Ideal poster size is: Landscape format (16:9 ratio). You may use PowerPoint or any program that can be converted to PDF.
- Slide size: 10 in x 5.625 in (25.4 cm x 14.288 cm)
- It is strongly recommended to use a clear typeface (Arial, Arial black, Calibri...) and regular text size not less than 28 for the body of the different sections (depending on the amount of ePosters you will be adding and, of course, the design you are using).
- The ePoster must be one slide.
- For images/pictures or graphs, the suggested resolution is 300 dpi. To check that they appear correctly on the final/printed version, zoom in at 100% and check the images, pictures and graphs. It is better to use high quality images/graphs when creating the poster and then convert it to PDF (as PDF files can be compressed).
- Provide clear labels or headings for each section of your presentation to avoid confusion.
- On light backgrounds (white, yellow, light blue) use dark fonts (black, navy blue, dark green).
- On dark backgrounds (blue, purple) use light fonts (white, yellow, cyan etc).
The heading indicates the title of the paper, author(s), institution, and location.
Each section can be numbered with text in a font size to guide the attendee through your poster. Color is an effective method for separating sections and adding graphic impact. Try to avoid color combinations that are difficult to read.
Your poster should include three-to-five brief sentences outlining the information necessary to understand the study, and why it was done. The question(s) to be asked or the hypotheses to be tested should be clearly and succinctly stated.
Outline your methods briefly, providing only details for new methods, or modifications of older methods.
Results presented in the form of a graph or chart are always more effective than blocks of text. Provide a legend for symbols and other details, and interpretation of results below each panel.
State the conclusion succinctly in large type. (Many viewers read this first, so it should be concise and easy to understand.)
All attendees, members of the media, companies, institutions, organizations, universities, investment advisors, and all other individuals, are required to abide by AASLD’s Abstract Embargo Policy governing The Liver Meeting®. An embargo means that information from any abstract or presentation is confidential and may not be announced, publicized, or distributed before the embargo date and time except as permitted by this policy.
Accepted abstracts are made available to the public on the AASLD website in early October and are published in the October supplement of HEPATOLOGY. Late-breaking abstracts will be available on the AASLD website and the online planner of The Liver Meeting® app November 1 at 10:00 am ET and are published in the December issue of HEPATOLOGY. Information contained in those abstracts may not be released until the abstracts appear on the AASLD website.
Academic institutions, private organizations, and companies with products whose values may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract on the AASLD website. However, information beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting is embargoed from release to the general public until 8:00am local time of the meeting location on the first day of the meeting.
The purpose of the embargo policy is to protect the scientific integrity of the abstract submissions presented at The Liver Meeting®. Violation of the embargo policy by release of information contained in any abstract prior to its embargoed date and time may result in the individual, as well as the employer/affiliated company, institution, organization, etc., being removed from The Liver Meeting®, with a potential two-year ban on returning. Authors are responsible for notifying financial and other sponsors about this policy.
View the Embargo Policy for more information.